Horizon Therapeutics announces acquisition by Amgen approved in Ireland
PremiumThe FlyHorizon Therapeutics announces acquisition by Amgen approved in Ireland
12M ago
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
Premium
The Fly
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
12M ago
Horizon Therapeutics announces new data on TEPEZZA treatment
Premium
The Fly
Horizon Therapeutics announces new data on TEPEZZA treatment
12M ago
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
PremiumPress ReleasesAMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
1y ago
Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit
Premium
The Fly
Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit
1y ago
Amgen to settle FTC and state challenges to Horizon Therapeutics takeover
Premium
The Fly
Amgen to settle FTC and state challenges to Horizon Therapeutics takeover
1y ago
Soros boosts stake in Amazon, exits position in First Horizon
PremiumThe FlySoros boosts stake in Amazon, exits position in First Horizon
1y ago
Viridian Therapeutics price target lowered to $39 from $46 at Wells Fargo
Premium
The Fly
Viridian Therapeutics price target lowered to $39 from $46 at Wells Fargo
1y ago
Horizon Therapeutics reports Q2 EPS $1.20, consensus $1.11
Premium
The Fly
Horizon Therapeutics reports Q2 EPS $1.20, consensus $1.11
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100